EMEA (EUROPE, MIDDLE EAST AND AFRICA) PHENYLKETONURIA (PKU) MARKET 2017 FORECAST TO 2022

Jan 2018 122

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.

Scope of the Report:

This report focuses on the Phenylketonuria (PKU) in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  • Biomarin
  • Vitaflo
  • Mead Johnson
  • Nutricia
  • Cambrooke
  • Dr. Schr
  • Prominmetabolics
  • PKU Perspectives

Market Segment by Regions, regional analysis covers

  • Europe (Germany, France, UK, Russia, Italy and Turkey)
  • Middle East (Saudi Arabia, Israel, UAE and Iran)
  • Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

  • Medications
  • Supplements
  • Others

Market Segment by Applications, can be divided into

  • Household
  • Hospital
  • Others

There are 13 Chapters to deeply display the EMEA Phenylketonuria (PKU) market.

Chapter 1, to describe Phenylketonuria (PKU) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Phenylketonuria (PKU), with sales, revenue, and price of Phenylketonuria (PKU), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Phenylketonuria (PKU), for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Phenylketonuria (PKU) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Phenylketonuria (PKU) research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Table of Contents

Related reports :

(Apr 18)

Vitamin K2 is the term for a group of compounds called ‘menaquinones,’ which can be found mainly in dairy products. All K vitamins are simil...

(Apr 18)

"Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by th...

(Apr 18)

"Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from l...

(Apr 18)

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both ...

(Apr 18)

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent ...

(Apr 18)

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at nigh...

EMEA (EUROPE, MIDDLE EAST AND AFRICA) PHENYLKETONURIA (PKU) MARKET 2017 FORECAST TO 2022


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*